Youshi Zheng (Ziguo Lin)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Ulcerative Colitis

Hyaluronic Acid

Natural Killer Cells

Top Venues

Angewandte Chemie (International ed. in English)

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Qiuyu Zhuang, Zhiguo Dai, Xuechun Xu, Shaoyi Bai, Yindan Zhang, Youshi Zheng, Xiaohua Xing, En Hu, Yingchao Wang, Wuhua Guo, Bixing Zhao, Yongyi Zeng, Xiao-Long Liu
RNA methyltransferase FTSJ3 regulates the type I interferon pathway to promote hepatocellular carcinoma immune evasion. Cancer research (2023)
Qingfu Zhao, Yunhao Wang, Binyu Zhao, Hengkai Chen, Zhixiong Cai, Youshi Zheng, Yongyi Zeng, Da Zhang, Xiao-Long Liu
Neoantigen Immunotherapeutic-Gel Combined with TIM-3 Blockade Effectively Restrains Orthotopic Hepatocellular Carcinoma Progression. Nano letters 22 (5) (2022)
Da Zhang, Ziguo Lin, Youshi Zheng, Jibin Song, Juan Li, Yongyi Zeng, Xiao-Long Liu
Ultrasound-Driven Biomimetic Nanosystem Suppresses Tumor Growth and Metastasis through Sonodynamic Therapy, CO Therapy, and Indoleamine 2,3-Dioxygenase Inhibition. ACS nano 14 (7) (2020)
Da Zhang, Youshi Zheng, Youshi Zheng, Xiao-Long Liu, Juan Li, Huang-Hao Yang, Weihong Tan
Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors. Angewandte Chemie (International ed. in English) 59 (29) (2020)
Ming Wu, Xinyi Lin, Xionghong Tan, Jiong Li, Zuwu Wei, Da Zhang, Youshi Zheng, Ai-Xian Zheng, Bixing Zhao, Yongyi Zeng, Xiao-Long Liu, Jingfeng Liu
Photoresponsive Nanovehicle for Two Independent Wavelength Light-Triggered Sequential Release of P-gp shRNA and Doxorubicin To Optimize and Enhance Synergistic Therapy of Multidrug-Resistant Cancer. ACS applied materials & interfaces 10 (23) (2018)